METIPRANOLOL Drug Patent Profile
✉ Email this page to a colleague
When do Metipranolol patents expire, and when can generic versions of Metipranolol launch?
Metipranolol is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in METIPRANOLOL is metipranolol hydrochloride. There are two drug master file entries for this compound. Additional details are available on the metipranolol hydrochloride profile page.
Summary for METIPRANOLOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 4,028 |
DailyMed Link: | METIPRANOLOL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METIPRANOLOL
US Patents and Regulatory Information for METIPRANOLOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | METIPRANOLOL | metipranolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075720-001 | Aug 6, 2001 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |